ReviewPharmacoEconomics2009

Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Anthony T Newall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.